Hefei Lifeon Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100004BD9
CNY
26.83
0.52 (1.98%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
367.01
354.73
387.60
350.80
428.85
328.81
370.75
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
367.01
354.73
387.60
350.80
428.85
328.81
370.75
Raw Material Cost
136.41
140.10
138.16
127.64
123.06
110.80
111.07
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.14
0.26
0.99
0.09
0.60
0.23
0.75
Selling and Distribution Expenses
164.24
162.87
175.83
169.73
234.08
171.08
182.24
Other Expenses
2.93
1.66
3.59
1.59
1.14
2.21
2.32
Total Expenditure (Excl Depreciation)
331.10
319.87
350.87
313.35
369.10
304.19
317.23
Operating Profit (PBDIT) excl Other Income
35.9
34.900000000000006
36.7
37.400000000000006
59.699999999999996
24.6
53.5
Other Income
26.13
9.70
-0.35
6.74
7.73
3.77
18.45
Operating Profit (PBDIT)
80.08
65.17
57.29
68.67
79.25
45.59
81.85
Interest
1.14
0.26
0.99
0.09
0.60
0.23
0.75
Exceptional Items
0.18
-0.04
0.35
-0.21
0.49
0.97
-2.07
Gross Profit (PBDT)
230.61
214.63
249.44
223.16
305.78
218.02
259.69
Depreciation
23.27
23.27
23.99
23.99
19.26
19.26
13.58
Profit Before Tax
55.85
41.60
32.67
44.38
59.87
27.07
65.45
Tax
4.46
4.89
3.67
4.71
9.40
1.55
5.46
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
51.98
38.25
41.62
41.55
47.06
30.37
55.30
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
51.98
38.25
41.62
41.55
47.06
30.37
55.30
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.28
1.03
-4.79
-1.88
1.48
-2.92
5.75
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
52.25
39.28
36.82
39.66
48.54
27.46
61.05
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,766.98
1,775.97
1,737.89
1,731.71
1,692.41
1,714.93
1,685.53
Earnings per share (EPS)
0.27
0.2
0.22
0.22
0.25
0.16
0.29
Diluted Earnings per share
0.27
0.2
0.22
0.22
0.25
0.16
0.29
Operating Profit Margin (Excl OI)
8.36%
9.08%
8.68%
10.82%
12.19%
6.86%
13.44%
Gross Profit Margin
21.56%
18.29%
14.62%
19.49%
18.45%
14.09%
21.32%
PAT Margin
14.16%
10.78%
10.74%
11.84%
10.97%
9.24%
14.91%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is -14.41% vs -5.07% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 7.84% vs -25.38% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is -24.48% vs 28.37% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is 83.33% vs -45.45% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024

Compare Quarterly Results Of Hefei Lifeon Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
367.01
0
367.01
Other Operating Income
0.00
0.00
0.00
Total Operating income
367.01
0
367.01
Raw Material Cost
136.41
0
136.41
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.14
0
1.14
Selling and Distribution Expenses
164.24
0
164.24
Other Expenses
2.93
0.00
2.93
Total Expenditure (Excl Depreciation)
331.10
0
331.10
Operating Profit (PBDIT) excl Other Income
35.92
0.00
35.92
Other Income
26.13
0
26.13
Operating Profit (PBDIT)
80.08
0
80.08
Interest
1.14
0
1.14
Exceptional Items
0.18
0
0.18
Gross Profit (PBDT)
230.61
0
230.61
Depreciation
23.27
0
23.27
Profit Before Tax
55.85
0
55.85
Tax
4.46
0
4.46
Provisions and contingencies
0
0
0.00
Profit After Tax
51.98
0
51.98
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
51.98
0
51.98
Share in Profit of Associates
0
0
0.00
Minority Interest
0.28
0
0.28
Other related items
0.00
0.00
0.00
Consolidated Net Profit
52.25
0
52.25
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,766.98
0
1,766.98
Earnings per share (EPS)
0.27
0
0.27
Diluted Earnings per share
0.27
0
0.27
Operating Profit Margin (Excl OI)
8.36%
0%
0.00
8.36%
Gross Profit Margin
21.56%
0%
0.00
21.56%
PAT Margin
14.16%
0%
0.00
14.16%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 36.70 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 3.47% vs -8.49% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -14.41% vs -5.07% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.23 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 33.08% vs 6.79% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 7.84% vs -25.38% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.40 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -2.70% vs -3.65% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -24.48% vs 28.37% in Jun 2024

Quarterly - Interest
Interest 0.11 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 266.67% vs -70.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 83.33% vs -45.45% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.36%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024